Wesbanco Bank Inc. decreased its stake in shares of RTX Co. (NYSE:RTX – Free Report) by 5.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 163,940 shares of the company’s stock after selling 8,856 shares during the period. Wesbanco Bank Inc.’s holdings in RTX were worth $18,971,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of RTX. MidAtlantic Capital Management Inc. bought a new stake in RTX during the third quarter worth about $29,000. Modus Advisors LLC bought a new stake in RTX during the fourth quarter worth about $39,000. Western Pacific Wealth Management LP bought a new stake in RTX during the third quarter worth about $41,000. Kimelman & Baird LLC purchased a new position in RTX in the second quarter worth about $46,000. Finally, ORG Wealth Partners LLC purchased a new position in RTX in the third quarter worth about $50,000. Institutional investors own 86.50% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on RTX shares. Barclays lifted their target price on shares of RTX from $108.00 to $130.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 29th. UBS Group lifted their target price on shares of RTX from $126.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, October 23rd. TD Cowen raised shares of RTX to a “strong-buy” rating in a report on Tuesday, October 8th. Wells Fargo & Company lifted their target price on shares of RTX from $140.00 to $151.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Finally, Deutsche Bank Aktiengesellschaft raised shares of RTX from a “hold” rating to a “buy” rating and lifted their target price for the stock from $131.00 to $140.00 in a report on Thursday, January 2nd. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $158.27.
RTX Stock Down 1.0 %
Shares of RTX stock opened at $124.49 on Thursday. RTX Co. has a 12 month low of $87.96 and a 12 month high of $128.70. The stock has a market cap of $165.69 billion, a P/E ratio of 35.57, a P/E/G ratio of 2.01 and a beta of 0.81. The company has a current ratio of 0.99, a quick ratio of 0.73 and a debt-to-equity ratio of 0.62. The company has a 50 day simple moving average of $118.10 and a two-hundred day simple moving average of $118.06.
RTX (NYSE:RTX – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.34 by $0.11. The business had revenue of $20.09 billion during the quarter, compared to analysts’ expectations of $19.84 billion. RTX had a net margin of 5.97% and a return on equity of 11.96%. The firm’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.25 earnings per share. On average, research analysts expect that RTX Co. will post 5.56 earnings per share for the current year.
About RTX
RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations.
Recommended Stories
- Five stocks we like better than RTX
- Ride Out The Recession With These Dividend KingsĀ
- 3 Small-Cap Stocks Insiders and Institutions Are Buying
- What Are Growth Stocks and Investing in Them
- MaxCyte: Building the Future of Cell and Gene Therapy Innovation
- Financial Services Stocks Investing
- Oracle Announces Game-Changing News for the AI Industry
Receive News & Ratings for RTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTX and related companies with MarketBeat.com's FREE daily email newsletter.